Stay updated on ABBV-8E12 Efficacy & Safety in Early Alzheimer's Clinical Trial

Sign up to get notified when there's something new on the ABBV-8E12 Efficacy & Safety in Early Alzheimer's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABBV-8E12 Efficacy & Safety in Early Alzheimer's Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The NIH transition announcement banner was removed from the page; the 403 error message remains.
    Difference
    1%
    Check dated 2026-11-09T14:43:54.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-02T16:22:07.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A notice about NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the page content. The clinical trial record itself remains unavailable.
    Difference
    1%
    Check dated 2026-10-26T15:43:07.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T17:13:27.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision indicator changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T17:57:29.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the usual study details with an access-denied screen; as a result, core trial information and documents are not visible.
    Difference
    21%
    Check dated 2026-09-21T22:08:47.000Z thumbnail image

Stay in the know with updates to ABBV-8E12 Efficacy & Safety in Early Alzheimer's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABBV-8E12 Efficacy & Safety in Early Alzheimer's Clinical Trial page.